Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
SYRE
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
SYRE: Spyre Therapeutics, Inc. Stock Analysis | finqOS
SYRE
$93.47
−4.26%
Lists
Call SYRE
Spyre Therapeutics
SYRE
Back
Lists
Call SYRE
$93.47
−$4.16 · −4.26%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
12%
in three months and
80%
of the way up its 52-week range.
Call SYRE
Loading chart data...
Signal state